Glucagon-like peptide-1
US$ 27.65
michigan semaglutide gi obstruction lawsuit gastrointestinal class action Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) At least 3,000 patients have
Description
The prescribing information for both medications specifically advises against combining GLP-1 receptor agonists
Prior Authorization Requirements: In most cases, approval requires demonstrating medical necessity through labs, clinical history, and prior treatments
95%CI: 0.70-0.98)
[Accessed 26/01/2026] 9 at-home treatments for acid reflux
